CANADA PENSION PLAN INVESTMENT BOARD
PensionPosition in SANA — Sana Biotechnology, Inc.
CIK 1283718
TORONTO ONTARIO, A6
Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,662,216
+$6,223,144 QoQ
Shares Held
10,218,400
-0.0% QoQ
Ownership
3.41%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA PENSION PLAN INVESTMENT BOARD holds $1,122,840,645 across 119 Biotechnology names. SANA ranks #9 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
355,082 | $176,379,881 | |
| 2 | KLRA |
Kailera Therapeutics, Inc.
|
7,304,688 | $160,922,276 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
209,911 | $130,887,904 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
334,246 | $100,618,073 | |
| 5 | ARGX |
Argenx SE
|
60,577 | $56,201,523 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
225,400 | $55,171,158 | |
| 7 | INCY |
Incyte Corp
|
442,500 | $50,161,800 | |
| 8 | SPTX |
Seaport Therapeutics, Inc.
|
1,975,791 | $42,914,180 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,662,216 | 10,218,400 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,439,072 | 10,221,900 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,685,347 | 10,242,100 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $36,121,250 | 10,175,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $27,777,750 | 10,175,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,094,000 | 10,175,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,585,250 | 10,175,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $42,328,000 | 10,175,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $55,555,500 | 10,175,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $101,750,000 | 10,175,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $41,514,000 | 10,175,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $39,377,250 | 10,175,000 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $60,643,000 | 10,175,000 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $33,272,250 | 10,175,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,191,250 | 10,175,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $61,050,000 | 10,175,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $65,425,250 | 10,175,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $84,045,500 | 10,175,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $157,509,000 | 10,175,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $229,141,000 | 10,175,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $200,040,500 | 10,175,000 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $340,557,250 | 10,175,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||